Skye Bioscience, Inc. Proceeds from Sale and Collection of Notes Receivable
Skye Bioscience, Inc. (SKYE) reported Proceeds from Sale and Collection of Notes Receivable of $21.23 thousand for the 9-month period ending 2014-07-31, per its 10-Q filed 2014-09-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable · last filed 2014-09-15
- Skye Bioscience, Inc. proceeds from sale and collection of notes receivable for the quarter ending 2014-07-31 was $10.75K, a 907.50% increase year-over-year.
- Skye Bioscience, Inc. proceeds from sale and collection of notes receivable for the quarter ending 2014-04-30 was $5.86K, a 38.73% decline year-over-year.
- Skye Bioscience, Inc. proceeds from sale and collection of notes receivable for the quarter ending 2014-01-31 was $4.63K, a 27105.88% increase year-over-year.
- Skye Bioscience, Inc. proceeds from sale and collection of notes receivable for the quarter ending 2013-07-31 was $1.07K.
| Period end | Proceeds from Sale and Collection of Notes Receivable 3 month | Proceeds from Sale and Collection of Notes Receivable 6 month | Proceeds from Sale and Collection of Notes Receivable 9 month |
|---|---|---|---|
| 2014-07-31 | $10.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | $16.61K derived: sum of 2 quarters · filed 2014-09-15 | $21.23K 10-Q · filed 2014-09-15 |
| 2014-04-30 | $5.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-05 | $10.48K 10-Q · filed 2014-06-05 | |
| 2014-01-31 | $4.63K 10-Q · filed 2014-03-17 | ||
| 2013-07-31 | $1.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | $10.62K derived: sum of 2 quarters · filed 2014-09-15 | $10.64K 10-Q · filed 2014-09-15 |
| 2013-04-30 | $9.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-05 | $9.57K 10-Q · filed 2014-06-05 | |
| 2013-01-31 | $17.00 10-Q · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |